Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02981758 · ClinicalTrials.gov registry record
Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT)
A clinical trial, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 300
- Enrollment target
NCT02981758: Completed study, sponsored by Hackensack Meridian Health.
NCT02981758 is a clinical trial that has completed, run by Hackensack Meridian Health. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02981758 has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
A comparison of reported estimated blood loss with quantified blood loss in all patients whose medical records indicate Triton was used during their vaginal delivery.
Primary Outcome
Retrospective Chart Review of blood loss during delivery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-09 |
What the finished NCT02981758 record still lists
NCT02981758 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02981758 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02981758 about?
NCT02981758 is a clinical study titled "Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT)". A comparison of reported estimated blood loss with quantified blood loss in all patients whose medical records indicate Triton was used during their vaginal delivery.
What is the current status of trial NCT02981758?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2016-07. Estimated completion is 2019-09.
Who is sponsoring clinical trial NCT02981758?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia